Wed, Sep 17, 2014, 8:48 AM EDT - U.S. Markets open in 42 mins.

Recent

% | $
Quotes you view appear here for quick access.

Enzon Pharmaceuticals Inc. Message Board

  • one1badbilly one1badbilly May 7, 2013 11:46 PM Flag

    The World Market PEGylated Protiens $7B in 2012, Growing Faster than Biopharma or Pharma

    "PEGylation first hit the mainstream with the US Food and Drug Administration's (FDA's) 1990 approval of Enzon Pharmaceuticals's Adagen bovine adenosine deaminase, which is used to treat X-linked severe combined immunodeficiency disease (SCID). A full dozen PEGylated products have since been approved, and more are in research and development (R&D) pipelines even now. The worldwide market for PEGylated proteins was about $7 billion in 2012, according to figures from Mountain View Pharmaceuticals. Mark Saifer, the company's vice president and scientific director, predicts that “sales of PEGylated protein therapeutics will grow faster than the biopharmaceutical market, which itself is growing faster than the pharmaceutical market as a whole. I believe this to be true even though some of the earliest PEGylated protein drugs have attracted the attention of biosimilar developers.”"

    Search "BioProcess Special Report" "Jim Kling"

    Check it out, Enzon is/was one of a dozen world leading companies in PEGylation technology.

    Let me see if I get this right, Enzon's some 100+ patents and several of the key scientists (still treading water) are worth less than $1 million!!!! You have to be fkg kidding me!

    Conspiracy, robbery, piracy, fraud, call it what you like! I've been involved in market research for 25 years, 10 of those as a VP at a fortune 200 company, this is Bull Sheet!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ENZN
1.30-0.13(-9.09%)Sep 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.